https://clinicaltrials.gov/ct2/show/NCT04205851
Gimsilumab
Ascending Single/Multiple-Dose Phase 1 Study With KIN-1901 (Gimsilumab) in Healthy Subjects and Subjects With Ankylosing Spondylitis
https://clinicaltrials.gov/ct2/show/NCT04205851?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=12%2F06%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
Ascending Single/Multiple-Dose Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis
DESCRIPTION:
Conditions: Inflammation; Rheumatic Diseases
Interventions: Drug: KIN-1901; Drug: Placebo
Sponsor: Kinevant Sciences GmbH
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT04205851
FIRST POSTED:
Fri, 20 Dec 2019 12:00:00 EST
LAST UPDATE POSTED:
12/20/19 08:49AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT04205851?type=Intr&cond=ankylosing+spondylitis&phase=0124&lupd_s=12%2F06%2F2019&lupd_d=14&sort=nwst